A surge of rodent breakthroughs competed with pragmatic trial results, underscoring how discovery speed outstrips real‑world adoption. Simultaneously, evidence that half of chatbot medical answers are problematic and a projected $7.8 billion measles burden highlight a widening trust and policy gap, while bio‑inspired energy and biodegradation ideas test scalability.
Reddit
#biomedical research
#clinical trials
#artificial intelligence
#public health
#renewable energy
